# RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

> **NCT00956007** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Radiation Therapy Oncology Group** · enrollment: 702 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00956007
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2010-03-31
- **Primary completion:** 2023-09-05
- **Final completion:** 2029-08
- **Target enrollment:** 702 (ACTUAL)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956007, "RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00956007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*